Literature DB >> 5917308

Significance of excess lymph in the thoracic duct in patients with hepatic cirrhosis.

A E Dumont, M H Witte.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5917308     DOI： 10.1016/0002-9610(66)90210-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN： 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  8 in total

1.  Chylothorax as a complication of oesophageal sclerotherapy.

Authors:  S D Nygaard; H A Berger; R B Fick
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Chylothorax associated with thrombosis of the cranial vena cava.

Authors:  Ameet Singh; Brigitte A Brisson
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

3.  Thoracic duct changes in schistosomal hepatic fibrosis.

Authors:  A M Sadek; A Aboul-Enein; E Hassenein; A Ismail
Journal:  Gut       Date:  1970-01       Impact factor: 23.059

4.  Aspects of ascites.

Authors:  R Knill-Jones
Journal:  Postgrad Med J       Date:  1969-03       Impact factor: 2.401

5.  [Cannulation of the thoracic duct in the portal hypertension of liver cirrhosis].

Authors:  A Fritsch; K Mach
Journal:  Langenbecks Arch Chir       Date:  1968

Review 6.  Liver Lymphatic Imaging and Interventions: Resurrection of the Forgotten Knowledge.

Authors:  Maxim Itkin; Deborah Rabinowitz; Saebeom Hur
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

Review 7.  The lymphatic drainage of the peritoneal cavity with reference to the treatment of ascites by lympho-venous shunt.

Authors:  G Szabó
Journal:  Experientia       Date:  1976

8.  Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis.

Authors:  Claus Christian Pieper; Andreas Feißt; Carsten Meyer; Julian Luetkens; Michael Praktiknjo; Jonel Trebicka; Ulrike Attenberger; Christian Jansen
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.